What are the guidelines for inducing labor at 38 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Induction of Labor at 38 Weeks Gestation

Routine elective induction at 38 weeks is not recommended for low-risk pregnancies; induction should be reserved for medical or obstetric indications at this gestational age, with elective induction delayed until 39 weeks 0 days or later. 1, 2

Timing Guidelines for Elective Induction

Elective induction should never be performed before 39 weeks 0 days gestation due to increased neonatal respiratory morbidity and other adverse outcomes. 1, 3, 4 The FDA labeling for oxytocin explicitly states that available data are inadequate to define benefit-to-risk considerations for elective induction, emphasizing that oxytocin is indicated for medical rather than elective induction. 2

For Low-Risk Nulliparous Women

  • Elective induction at 39 weeks 0 days is recommended as it reduces cesarean delivery rates from 22.2% to 18.6% (number needed to treat = 28) and decreases hypertensive disorders from 14.1% to 9.1%. 1
  • This recommendation is supported by high-quality randomized trial evidence specifically in nulliparous women. 1, 5

For Multiparous Women

  • Evidence supporting elective induction at 39 weeks does not extend to multiparous women, as all high-quality trials were conducted exclusively in nulliparous populations. 3
  • Expectant management until spontaneous labor or development of medical indication may be more appropriate given the lack of specific evidence. 3

Medical Indications for Induction at 38 Weeks

Induction at 38 weeks is appropriate when continuing pregnancy poses greater risks than delivery. 1, 2 Specific indications include:

Hypertensive Disorders

  • Gestational hypertension or mild preeclampsia at 37 weeks or later warrants induction to improve maternal outcomes. 1

Fetal Growth Restriction

  • For FGR with normal umbilical artery Doppler and estimated fetal weight between 3rd-10th percentile, deliver at 38-39 weeks. 6
  • For FGR with abnormal Doppler (elevated resistance but preserved end-diastolic flow), deliver by 37-38 weeks depending on severity. 6
  • The U.S. guidelines recommend delivery at 38+0 to 39+6 weeks for FGR with no additional abnormal parameters. 6
  • New Zealand guidelines recommend delivery by 38 weeks if umbilical artery Doppler >95th percentile, middle cerebral artery <5th percentile, or cerebroplacental ratio <5th percentile. 6

Other Medical Indications at 38 Weeks

  • Maternal diabetes with poor glycemic control 1, 2
  • Rh disease requiring early delivery 2
  • Premature rupture of membranes at term 2

Critical Contraindications at 38 Weeks

Suspected fetal macrosomia is NOT an indication for induction at any gestational age, as it doubles cesarean risk without reducing shoulder dystocia or neonatal morbidity. 1

Previous cesarean delivery with misoprostol use carries a 13% uterine rupture risk and is absolutely contraindicated. 1

Common Pitfalls to Avoid

  • Do not perform elective induction before 39 weeks 0 days even if the cervix is favorable or the patient requests earlier delivery. 1, 3
  • Do not extrapolate nulliparous data to multiparous women when counseling about elective induction benefits. 3
  • Ensure clear documentation of medical indication if inducing at 38 weeks, as this is not considered elective timing. 2
  • Assess cervical favorability with Bishop score before selecting induction method; unfavorable cervix (Bishop <5) requires cervical ripening agents first. 3, 7

Cervical Ripening Methods at 38 Weeks

For unfavorable cervix at 38 weeks with medical indication:

  • Single-balloon Foley catheter (60-80 mL) for 12 hours combined with either oral misoprostol (25 μg every 2-4 hours or 50 μg every 4-6 hours) or oxytocin infusion is recommended. 8
  • Dinoprostone gel is FDA-approved for cervical ripening at or near term with medical or obstetrical need. 7
  • Avoid misoprostol in patients with previous uterine surgery and dinoprostone in those with active cardiovascular disease. 1

References

Guideline

Induction of Labour Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Induction of Labour in Multiparous Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Induction of labor: update and review.

Journal of midwifery & women's health, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evidence-based labor management: induction of labor (part 2).

American journal of obstetrics & gynecology MFM, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.